Skip to main content

Cardiovascular

Featured Article
Researchers found that patients with atrial fibrillation commonly use nonsteroidal anti-inflammatory drugs along with oral anticoagulants, a practice that increases their risk of bleeding.
Researchers recently assessed fracture risk among older adults taking warfarin compared to those taking direct oral anticoagulants, and found that warfarin was associated with increased risk of…

Insights

Mark Munger, PharmD, discusses recent study findings, which show that ranolazine increases the adverse effect profile of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, raising concern for patient safety.
Kiersten Combs, vice president of US Cardiovascular & Metabolic Disease, and Jim McDermott, vice president of US Medical Affairs and Metabolism, both at AstraZeneca, highlight how the use of Farxiga and other SGLT2 inhibitors impact payers and…
Mark Munger, PharmD, explains why there is a critical need to develop a treatment to reduce the incidence of NSAID-induced cardiovascular adverse events, especially heart failure.
In this expert blog post, Mark Munger, PharmD, explains why control of blood pressure is multifactorial.

Interactive Features

Most patients who received guideline-recommended medication had doses lower than those recommended, the researchers note.
What percentage of Medicare beneficiaries do not take their blood pressure medications as directed, according to the CDC?
A minimum of ___________ should elapse before patients who take patiromer for treatment of hyperkalemia ingest other oral medications.
Back to Top